Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:ADMS
Delisted

Adamas Pharmaceuticals Stock Price (Quote)

$8.22
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $8.22 $8.22 Friday, 27th May 2022 ADMS stock ended at $8.22. During the day the stock fluctuated 0% from a day low at $8.22 to a day high of $8.22.
90 days $8.22 $8.22
52 weeks $4.02 $8.25

Historical Adamas Pharmaceuticals prices

Date Open High Low Close Volume
Sep 30, 2016 $16.41 $16.41 $16.41 $16.41 179 000
Sep 29, 2016 $16.50 $16.50 $16.50 $16.50 239 800
Sep 28, 2016 $17.46 $17.46 $17.46 $17.46 162 800
Sep 27, 2016 $17.30 $17.30 $17.30 $17.30 246 800
Sep 26, 2016 $17.65 $17.65 $17.65 $17.65 161 100
Sep 23, 2016 $17.35 $17.35 $17.35 $17.35 187 400
Sep 22, 2016 $18.07 $18.07 $18.07 $18.07 261 200
Sep 21, 2016 $17.81 $17.81 $17.81 $17.81 594 100
Sep 20, 2016 $18.09 $18.09 $18.09 $18.09 309 300
Sep 19, 2016 $17.68 $17.68 $17.68 $17.68 222 600
Sep 16, 2016 $17.42 $17.42 $17.42 $17.42 234 700
Sep 15, 2016 $16.86 $16.86 $16.86 $16.86 283 700
Sep 14, 2016 $16.45 $16.45 $16.45 $16.45 233 000
Sep 13, 2016 $15.89 $15.89 $15.89 $15.89 197 300
Sep 12, 2016 $15.77 $15.77 $15.77 $15.77 168 400
Sep 09, 2016 $15.11 $15.11 $15.11 $15.11 244 000
Sep 08, 2016 $16.13 $16.13 $16.13 $16.13 406 000
Sep 07, 2016 $15.63 $15.63 $15.63 $15.63 199 200
Sep 06, 2016 $15.19 $15.19 $15.19 $15.19 158 000
Sep 02, 2016 $14.76 $14.76 $14.76 $14.76 269 200
Sep 01, 2016 $15.07 $15.07 $15.07 $15.07 441 300
Aug 31, 2016 $13.67 $13.67 $13.67 $13.67 690 100
Aug 30, 2016 $12.99 $12.99 $12.99 $12.99 171 600
Aug 29, 2016 $13.11 $13.11 $13.11 $13.11 141 700
Aug 26, 2016 $13.11 $13.11 $13.11 $13.11 292 500
Click to get the best stock tips daily for free!

About Adamas Pharmaceuticals

Adamas Pharmaceuticals Adamas Pharmaceuticals, Inc., a pharmaceutical company, focuses on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. The company’s lead product candidate is the ADS-5102 that is in Phase 3 clinical development for the treatment of levodopa-induced dyskinesia, a movement disorder associated with Parkinson’s disease; and in a Phase 2 clinical study for the treatment of symptoms assoc... ADMS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT